Halozyme Therapeutics reported $81.63M in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Amarin AMRN:US $ -28.35M 44.74M
Amgen AMGN:US $ 2727M 56M
Baxter International BAX:US $ 492M 157M
Cara Therapeutics CARA:US $ -27749000 5.63M
Cytokinetics CYTK:US $ -86.75M 56.18M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Immunogen IMGN:US $ -24.14M 13.03M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
Intrexon XON:US $ -19.31M 5.71M
JAZZ PHA JAZZ:US $ 321.29M 19.04M
Mannkind MNKD:US $ -26M 2.06M
Minerva Neurosciences NERV:US $ -9.76M 13.35M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Peregrine Pharmaceuticals PPHM:US $ 2.25M 1.27M
Pfizer PFE:US $ 11328M 4083M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
United Therapeutics UTHR:US $ 308.7M 168.2M
Vanda Pharmaceuticals VNDA:US $ -7.56M 16.17M